Adjuvant-Enhanced mRNA Vaccines

Methods Mol Biol. 2017:1499:179-191. doi: 10.1007/978-1-4939-6481-9_11.

Abstract

Recent advances in molecular biology have led to dramatic enhancement of the stability of in vitro transcribed (IVT) messenger RNA (mRNA) and improvement in its translational efficacy. Nowadays, mRNA-based vaccines represent a promising approach in the field of anticancer immunotherapy, gaining attention over the earlier-established bacteria-, virus-, or cell-based vaccination approaches. Here, we present the experimental procedures employed in our laboratory to induce anticancer immune responses in different murine tumor models using IVT mRNA encoding for immune activation signals and antigens of interest.

Keywords: Bioluminescence imaging; Cancer immunotherapy; Dendritic cells; Electroporation; Intralymphatic; Intranodal; Intratumoral; Therapeutic vaccine; mRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Neoplasm / immunology
  • Cancer Vaccines / immunology*
  • Dendritic Cells / immunology
  • Female
  • Humans
  • Immunotherapy / methods
  • Mice
  • Mice, Inbred C57BL
  • RNA, Messenger / immunology*
  • Vaccination / methods

Substances

  • Antigens, Neoplasm
  • Cancer Vaccines
  • RNA, Messenger